Active substance (DCI)
- eculizumab
history (6)
-
3/22/23
SOLIRIS (éculizumab) - Atypical haemolytic uraemic syndrome (aHUS)
CAV : -
9/16/20
SOLIRIS
CAV : -
6/27/18
SOLIRIS (eculizumab)
-
6/26/13
SOLIRIS (eculizumab)
-
9/19/12
SOLIRIS
CAV : -
10/24/07
SOLIRIS (eculizumab)
CAV :